Alterations in downstream targets of Akt such as the mammalian target of rapamycin (mTOR) pathway have recently also been shown to have significant effects on tumor progression in melanoma but we were unable to find any published literature supporting a relationship between EPO-mediated tumor proliferation and the mTOR pathway [41]. This evidence concerns the gene AKT1 and melanoma.